HER2 Low Status and Intratumoral Heterogeneity in Epithelial Malignancies and Their Therapeutic Implications
Sign Up to like & getrecommendations! Published in 2025 at "Indian Journal of Medical and Paediatric Oncology"
DOI: 10.1055/s-0045-1812851
Abstract: Abstract Human epidermal growth factor receptor 2 (HER2) continues to serve as a critical biomarker in breast cancer, but the introduction of evolving classifications such as HER2-low and HER2-ultra-low presents both opportunities and challenges in… read more here.
Keywords: oncology; her2 low; low status; status intratumoral ... See more keywords